Back
Teva Pharmaceutical Industries Stock Predictions
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
TEVA
Teva Pharmaceutical Industries
Last Price:
$16.23
Seasonality Move:
4.57%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the Founder that's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Teva Pharmaceutical Industries Stock Forecast
-
Over the next 52 weeks, Teva Pharmaceutical Industries has on average historically risen by 15.7% based on the past 43 years of stock performance.
-
Teva Pharmaceutical Industries has risen higher in 25 of those 43 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.14%
-
Is Teva Pharmaceutical Industries Stock Undervalued?The current Teva Pharmaceutical Industries [TEVA] share price is $16.29. The Score for TEVA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
TEVA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Teva Pharmaceutical Industries Stock Go Up Next Year?
-
Over the next 52 weeks, Teva Pharmaceutical Industries has on average historically risen by 15.7% based on the past 43 years of stock performance.
Teva Pharmaceutical Industries Stock Rating
Sell
32
Teva Pharmaceutical Industries (TEVA)
is a Sell
Is Teva Pharmaceutical Industries overpriced?
-
Teva Pharmaceutical Industries has risen higher in 25 of those 43 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.14%
Teva Pharmaceutical Industries Stock Price History
Stock Information
Stock Info
Exchange:
NYSE
Country:
Israel
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
tevapharm.com
52-Week Data
52-Week High:
22.80
52-Week Low:
12.51
Prediction Charts
Market Cap:
18.5B
Price in USD:
16.29
Volume:
9.2M
Beta:
0.59
Technical Analysis
SMA50:
18.29
SMA100:
18.32
SMA200:
17.84
52-Wk Change:
22.02%
Stock Predictions
-
Is Teva Pharmaceutical Industries stock public?Yes, Teva Pharmaceutical Industries is a publicly traded company.
-
What is the Teva Pharmaceutical Industries stock quote today?The Teva Pharmaceutical Industries stock price is 16.29 USD today.
-
How to buy Teva Pharmaceutical Industries stock online?You can buy Teva Pharmaceutical Industries shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-27 | 16.65 | 16.32 | 16.89 | 16.28 |
| Feb-28 | 16.22 | 16.46 | 16.46 | 16.06 |
| Mar-3 | 16.44 | 16.00 | 16.53 | 15.86 |
| Mar-4 | 15.70 | 15.69 | 16.06 | 15.27 |
| Mar-5 | 15.69 | 15.90 | 16.13 | 15.68 |
| Mar-6 | 15.58 | 15.35 | 15.74 | 15.17 |
| Mar-7 | 15.35 | 15.36 | 15.46 | 15.02 |
| Mar-11 | 14.68 | 16.10 | 16.22 | 14.67 |
| Mar-12 | 16.22 | 16.48 | 16.71 | 16.05 |
| Mar-13 | 16.39 | 16.46 | 16.92 | 16.22 |
| Mar-14 | 16.46 | 16.33 | 16.51 | 16.17 |
| Mar-17 | 16.25 | 16.71 | 16.89 | 16.23 |
| Mar-18 | 16.65 | 16.48 | 16.70 | 16.23 |
| Mar-19 | 16.43 | 16.29 | 16.57 | 16.06 |
Teva Pharmaceutical Industries Earnings
Teva Pharmaceutical Industries Earnings Report: Per Share Teva Pharmaceutical Industries Earnings Q1 Q2 Q3 and Q4 last year and next year.
Teva Pharmaceutical Industries Forecast Revenue Growth
Teva Pharmaceutical Industries Stock Analysis: Historical quarterly revenues per share for Teva Pharmaceutical Industries and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.08 per share, and an increase next year of $0.21 per share.
* Teva Pharmaceutical Industries stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.